Stay updated with breaking news from Newg Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acquisition transforms Nuvation Bio into late-stage global oncology company with potential to become a commercial organization by the end of 2025 Acquisition adds taletrectinib, a next-generation,...
Actress Park Yoo Na has recently parted ways with Bright Entertainment, citing the agency's deteriorating management as the reason for terminating he…
AnHeart and NewG Lab have received orphan drug designation in Korea for the taletrectinib to treat advanced or metastatic ROS1-positive NSCLC.
/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...
AnHeart and Innovent have entered an exclusive licence agreement to co-develop and market drug candidate taletrectinib in Greater China.